Seeing Is Believing
Currently out of the existing stock ratings of Tom Smith, 92 are a BUY (100%).
Analyst Tom Smith works at LEERINK with a stock forecast success ratio of 100% fulfilled within 9 days on average.
Tom Smith’s has documented 3 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KROS, Keros Therapeutics at 08-Dec-2020.
Analyst best performing recommendations are on KROS (KEROS THERAPEUTICS ).
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
105
$47.9 (83.89%)
110
1 months 6 days ago
5/11 (45.45%)
$40.34 (62.39%)
43
Buy
100
$42.9 (75.13%)
100
1 months 20 days ago
0/3 (0%)
$32.34 (47.80%)
Buy
100
$42.9 (75.13%)
100
2 months 2 days ago
1/7 (14.29%)
$31.15 (45.24%)
113
Buy
86
$28.9 (50.61%)
86
5 months 20 days ago
0/4 (0%)
$56.01 (186.76%)
Buy
105
$47.9 (83.89%)
80
1 years 4 months 20 days ago
0/2 (0%)
$53.23 (102.82%)
What Year was the first public recommendation made by Tom Smith?